MRI of geometric and compositional features of vulnerable carotid plaque

Stroke

Volumn 38, Issue 2 PART 2, 2007, Pages 637-641

  Saloner, David ^a,b   Acevedo Bolton, Gabriel ^a   Wintermark, Max ^a   Rapp, Joseph H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Carotid artery; Carotid stenosis; Hemodynamics; MR angiography; MRI

Indexed keywords

ARTERY WALL; ATHEROMA; BLOOD FLOW; BRAIN ARTERY; BRAIN BLOOD FLOW; CAROTID ARTERY OBSTRUCTION; CLINICAL FEATURE; CONFERENCE PAPER; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MEDICAL INFORMATION; NON INVASIVE MEASUREMENT; PRIORITY JOURNAL;

ANIMALS; ATHEROSCLEROSIS; CAROTID ARTERIES; CAROTID STENOSIS; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; SENSITIVITY AND SPECIFICITY;

EID: 33846680680     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000254127.52214.2b     Document Type: Conference Paper

References (38)

1. North American Symptomatic Carotid Endarterectomy Trial. Methods, patient characteristics, and progress. Stroke. 1991;22:711-720.
2. Eliasziw M, Smith RF, Singh N, Holdsworth DW, Fox AJ, Barnett HJ; North American Symptomatic Carotid Endarterectomy Trial (NASCET) Group. Further comments on the measurement of carotid stenosis from angiograms. Stroke. 1994;25:2445-2449.
3. Anderson CM, Lee RE, Levin DL, de la Torre Alonso S, Saloner D. Measurement of internal carotid artery stenosis from source MR angiograms. Radiology. 1994;193:219-226.
4. Aoki S, Nakajima H, Kumagai H, Araki T. Dynamic contrast-enhanced MR angiography and MR imaging of the carotid artery: high-resolution sequences in different acquisition planes. Ajnr Am Journal of Neuroradiology. 2000;21:381-385.
5. Huston III J, Fain SB, Wald JT, Luetmer PH, Rydberg CH, Covarrubias DJ, Riederer SJ, Bernstein MA, Brown RD, Meyer FB, Bower TC, Schleck CD. Carotid artery: elliptic centric contrast-enhanced MR angiography compared with conventional angiography. Radiology. 2001;218:138-143.
6. Parker DL, Yuan C, Blatter DD. MR angiography by multiple thin slab 3D acquisition. Magnetic Resonance in Medicine. 1991;17:434-451.
7. Golay X, Brown SJ, Itoh R, Melhem ER. Time-resolved contrast-enhanced carotid MR angiography using sensitivity encoding (sense). Ajnr Am Journal of Neuroradiology. 2001;22:1615-1619.
8. Carroll TJ, Korosec FR, Petermann GM, Grist TM, Turski PA. Carotid bifurcation: evaluation of time-resolved three-dimensional contrast-enhanced MR angiography. Radiology. 2001;220:525-532.
9. Lovett JK, Gallagher PJ, Hands LJ, Walton J, Rothwell PM. Histological correlates of carotid plaque surface morphology on lumen contrast imaging. Circulation. 2004;110:2190-2197.
10. Eliasziw M, Streifler JY, Fox AJ, Hachinski VC, Ferguson GG, Barnett HJ. Significance of plaque ulceration in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy trial. Stroke. 1994;25:304-308.
11. Coombs BD, Rapp JH, Ursell PC, Reilly LM, Saloner D. Structure of plaque at carotid bifurcation: high-resolution MRI with histological correlation. Stroke. 2001;32:2516-2521.
12. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med. 1987;316:1371-1375.
13. Toussaint JF, Pachot-Clouard M, Kantor HL. Tissue characterization of atherosclerotic plaque vulnerability by nuclear magnetic resonance. J Cardiovasc Magn Reson. 2000;2:225-232.
14. Yuan C, Petty C, O'Brien KD, Hatsukami TS, Eary JF, Brown BG. In vitro and in situ magnetic resonance imaging signal features of atherosclerotic plaque-associated lipids. Arterioscler Thromb Vasc Biol. 1997;17:1496-1503.
15. Hatsukami TS, Ross R, Polissar NL, Yuan C. Visualization of fibrous cap thickness and rupture in human atherosclerotic carotid plaque in vivo with high-resolution magnetic resonance imaging. Circulation. 2000;102:959-964.
16. Fisher M, Blumenfeld AM, Smith TW. The importance of carotid artery plaque disruption and hemorrhage. Archives of Neurology. 1987;44:1086-1089.
17. Fleiner M, Kummer M, Mirlacher M, Sauter G, Cathomas G, Krapf R, Biedermann BC. Arterial neovascularization and inflammation in vulnerable patients: early and late signs of symptomatic atherosclerosis. Circulation. 2004;110:2843-2850.
18. Rauch U, Osende JI, Fuster V, Badimon JJ, Fayad Z, Chesebro JH. Thrombus formation on atherosclerotic plaques: pathogenesis and clinical consequences. Ann Intern Med. 2001;134:224-238.
19. Corti R, Fayad ZA, Fuster V, Worthley SG, Helft G, Chesebro J, Mercuri M, Badimon JJ. Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: a longitudinal study by high-resolution, noninvasive magnetic resonance imaging. Circulation. 2001;104:249-252.
20. Caro CG, Fitzgerald JM, Schroter RC. Atheroma and arterial wall shear: observation, corelation and proposal of a shear dependent mass transfer mechanism for arterogenesis. Proc Royal Society of London. 1971;B17:109-159.
21. Morigi M, Zoja C, Figliuzzi M, Foppolo M, Micheletti G, Bontempelli M, Saronni M, Remuzzi G, Remuzzi A. Fluid shear stress modulates surface expression of adhesion molecules by endothelial cells. Blood. 1995;85: 1696-1703.
22. Noris M, Morigi M, Donadelli R, Aiello S, Foppolo M, Todeschini M, Orisio S, Remuzzi G, Remuzzi A. Nitric oxide synthesis by cultured endothelial cells is modulated by flow conditions. Circ Res. 1995;76: 536-543.
23. Jou LD, Saloner D. A numerical study of magnetic resonance images of pulsatile flow in a two dimensional carotid bifurcation: a numerical study of MR images. Medical Engineering and Physics. 1998;20:643-652.
24. Chu B, Zhao XQ, Saam T, Yarnykh VL, Kerwin WS, Flemming KD, Huston III J, Insull W Jr, Morrisett JD, Rand SD, DeMarco KJ, Polissar NL, Balu N, Cai J, Kampschulte A, Hatsukami TS, Yuan C. Feasibility of in vivo, multicontrast-weighted MR imaging of carotid atherosclerosis for multicenter studies. J Magn Reson Imaging. 2005;21:809-817.
25. Phan BA, Chu B, Kerwin WS, Xu D, Yuan C, Hatsukami T, Zhao XQ. Effect of contrast enhancement on the measurement of carotid arterial lumen and wall volume using MRI. J Magn Reson Imaging. 2006;23: 481-485.
26. Kerwin WS, O'Brien KD, Ferguson MS, Polissar N, Hatsukami TS, Yuan C. Inflammation in carotid atherosclerotic plaque: a dynamic contrast-enhanced MR imaging study. Radiology. 2006;241:459-468.
27. Schmitz SA, Coupland SE, Gust R, Winterhalter S, Wagner S, Kresse M, Semmler W, Wolf KJ. Superparamagnetic iron oxide-enhanced MRI of atherosclerotic plaques in watanabe hereditable hyperlipidemic rabbits. Investigative Radiology. 2000;35:460-471.
28. Hyafil F, Laissy J-P, Mazighi M, Tchetche D, Louedec L, Adle-Biassette H, Chillon S, Henin D, Jacob M-P, Letourneur D, Feldman LJ. Ferumoxtran-10- enhanced MRI of the hypercholesterolemic rabbit aorta: relationship between signal loss and macrophage infiltration. Arterioscler Thromb Vasc Biol. 2006;26:176-181.
29. Trivedi RA, U-King-Im JM, Graves MJ, Kirkpatrick PJ, Gillard JH. Noninvasive imaging of carotid plaque inflammation. Neurology. 2004; 63:187-188.
30. Kooi ME, Cappendijk VC, Cleutjens KB, Kessels AG, Kitslaar PJ, Borgers M, Frederik PM, Daemen MJ, van Engelshoven JM. Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation. 2003;107:2453-2458.
31. Trivedi RA, Mallawarachi C, JM UK-I, Graves MJ, Horsley J, Goddard MJ, Brown A, Wang L, Kirkpatrick PJ, Brown J, Gillard JH. Identifying inflamed carotid plaques using in vivo uspio-enhanced MR imaging to label plaque macrophages. Arterioscler Thromb Vasc Biol. 2006;26: 1601-1606.
32. Frias JC, Williams KJ, Fisher EA, Fayad ZA. Recombinant hdl-like nanoparticles: a specific contrast agent for mri of atherosclerotic plaques. J Am Chem Soc. 2004;126:16316-16317.
33. Winter PM, Caruthers SD, Kassner A, Harris TD, Chinen LK, Allen JS, Lacy EK, Zhang H, Robertson JD, Wickline SA, Lanza GM. Molecular imaging of angiogenesis in nascent vx-2 rabbit tumors using a novel alpha(nu)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging. Cancer Res. 2003;63:5838-5843.
34. Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res. 2002; 90:251-262.
35. Amirbekian A, Aguinado G, Amirbekian V, Sirol M, Hyafil F, Vucic E, Mani V, Lancelot E, Corot C, Fayad Z. Imaging of atherosclerosis in vivo using a magnetic resonance contrast probe molecularly targeted to matrix metalloproteinases (MMPs). ISMRM. 2006;559.
36. Rodgers KJ, Watkins DJ, Miller AL, Chan PY, Karanam S, Brissette WH, Long CJ, Jackson CL. Destabilizing role of cathepsin s in murine atherosclerotic plaques. Arterioscler Thromb Vasc Biol. 2006;26:851-856.
37. Chen J, Tung CH, Mahmood U, Ntziachristos V, Gyurko R, Fishman MC, Huang PL, Weissleder R. In vivo imaging of proteolytic activity in atherosclerosis. Circulation. 2002;105:2766-2771.
38. Botnar RM, Perez AS, Witte S, Wiethoff AJ, Laredo J, Hamilton J, Quist W, Parsons EC Jr, Vaidya A, Kolodziej A, Barrett JA, Graham PB, Weisskoff RM, Manning WJ, Johnstone MT. In vivo molecular imaging of acute and subacute thrombosis using a fibrin-binding magnetic resonance imaging contrast agent. Circulation. 2004;109:2023-2029.